Trial Profile
Post-marketing clinical study of Ogamma 100 in patients with adult T-cell leukemia (ATL)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Jun 2016
Price :
$35
*
At a glance
- Drugs Interferon gamma (Primary)
- Indications Adult T-cell leukaemia-lymphoma
- Focus Adverse reactions; Therapeutic Use
- Sponsors Otsuka Pharmaceutical
- 10 Jun 2016 New trial record